Germany is falling well short of international targets for HPV vaccination, with just over half of 15-year-old girls fully immunized in 2024, according to a new German HPV atlas reported by Tagesspiegel. The figures place Europe's largest economy among the weaker performers on a measure that public health officials see as central to eliminating cervical cancer. The shortfall comes as a separate modeling study in Nature Medicine projects that cervical cancer cases and deaths will rise globally over the coming decades.
Why it matters
Nearly all cervical cancer cases trace back to infection with high-risk types of human papillomavirus, a link researchers established in the 1980s and 1990s. The virus spreads mainly through close mucosal contact, including during sex, which is why young people with changing partners are frequently infected. Estimates suggest 85 to 90 percent of men and women contract HPV at least once in their lives. Most infections clear without symptoms, and according to the German atlas, fewer than one percent lead to cancer.
Because the vaccine works best before exposure, timely immunization of adolescents is the most reliable protection available. Condoms, unlike their role against pathogens such as HIV, offer only limited defense against HPV. Germany has recommended the shot for girls aged 9 to 14 since 2007 and extended the recommendation to boys in the same age group in 2018, with statutory health insurers covering the cost.
The stakes are considerable. According to Robert Koch Institute estimates cited in the reporting, Germany recorded roughly 11,000 new HPV-related cancer cases in 2021 — about 7,600 in women and 3,000 in men. Cervical cancer is the most common HPV-linked cancer among women. The virus can also cause precancerous lesions whose treatment may require surgery.
A widening gap between regions and genders
The atlas, as described by Tagesspiegel, finds stark variation inside Germany. Among 15-year-old girls, Saxony-Anhalt reached a 70 percent full vaccination rate, the highest in the country, while Baden-Württemberg stood at 42 percent, the lowest. The national average of 55 percent is far from the World Health Organization's goal of fully immunizing 90 percent of girls by 2030 — a target the atlas expects Germany to miss.
Boys fare worse still: only 36 percent of 15-year-old boys nationwide were fully vaccinated in 2024. The authors also note that the recent pace of improvement has slowed markedly.
The atlas points to the structure of the delivery system as one obstacle. Responsibility for vaccination rests with family doctors, and cross-country comparisons suggest that programs run through schools tend to produce noticeably higher uptake than those delivered in medical practices.
A global forecast of rising cases
The German picture sits within a wider projection. A modeling study by Natalie Pritchett and Lisa Force of the University of Washington in Seattle, published in Nature Medicine, extends current trends to mid-century. It estimates that by 2050 about one million women worldwide could develop cervical cancer each year, roughly 20 percent more cases than in 2024. Annual deaths could reach some 522,000, an increase of nearly 40 percent.
The forecast diverges sharply by income level. In low- and middle-income countries, particularly in Sub-Saharan Africa and South Asia, cases and deaths are expected to climb as demographic change enlarges the pool of women at risk while vaccination and care remain inadequate. In wealthier countries, incidence and mortality rates per 100,000 women are projected to decline, though the total burden stays high as populations age.
The researchers cautioned that their results should not be read as a no-action scenario. Progress is occurring, they said, but their projections assume policy implementation continues at its current pace alongside demographic shifts and socioeconomic development.
The study's authors also expect many countries beyond Germany to miss the WHO's 2030 goals. Those targets include screening 70 percent of women aged 35 to 45 and treating 90 percent of women with cervical changes appropriately. By the researchers' projection, no world region will reach the threshold of four new cases per 100,000 women by 2050 — the level considered necessary to eliminate cervical cancer as a public health problem.
For Germany, the immediate question is whether health authorities will rethink how the vaccine is delivered. The atlas authors' comparison with other countries suggests school-based programs as one route to higher coverage. Whether that approach enters German policy — and whether uptake among boys can be lifted — will be the measure to watch in the run-up to 2030.
